Every SEC Form 3/4/5 on record for this filer (CIK 1656998) — 12 issuers, 41 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | Director | 2026-06-23 → 2026-06-23 | 2 | — |
| ADCT | ADC Therapeutics SA | Director | 2024-01-02 → 2026-06-03 | 6 | −$20,216 |
| TERN | Terns Pharmaceuticals, Inc. | Director | 2025-02-24 → 2026-05-05 | 4 | — |
| AUTL | Autolus Therapeutics plc | Director | 2026-03-18 → 2026-03-18 | 1 | — |
| CAH | CARDINAL HEALTH INC | Director | 2024-03-01 → 2025-11-06 | 4 | — |
| KDNY | CHINOOK THERAPEUTICS, INC. | Director · lapsed | 2023-04-12 → 2023-08-11 | 3 | — |
| ELYM | Eliem Therapeutics, Inc. | President & CEO · Director · lapsed | 2021-08-09 → 2022-11-02 | 3 | — |
| CLVS | Clovis Oncology, Inc. | Director · lapsed | 2018-10-12 → 2021-06-11 | 5 | — |
| IMMU | IMMUNOMEDICS INC | Director · lapsed | 2020-02-27 → 2020-10-23 | 4 | — |
| ALDR | ALDER BIOPHARMACEUTICALS INC | President and CEO · Director · lapsed | 2018-06-15 → 2019-10-24 | 5 | — |
| CASC | Cascadian Therapeutics, Inc. | Director · lapsed | 2017-04-04 → 2018-03-13 | 4 | — |
| JUNO | Juno Therapeutics, Inc. | EVP & Chief Commercial Officer · lapsed | 2015-11-02 → 2018-03-07 | 17 | −$14M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ADCT | 2024-06-17 | Sell | 6,995 | $2.89 | $20,216 | 53,005 |
4 of 12 issuers are covered and open a security page; the rest are on file here only.
